Christopher R. Dale & R. Guy Hudson
We should modernize our payment mechanisms to reflect the reality of our digitally enabled lives.
Roslyn Murray, Maclaine Lehan & Suzanne F. Delbanco
Innovative models are showing promise, but limited transparency and peer-reviewed research hamper expansion.
Adam Sacarny, Michael L. Barnett & Shantanu Agrawal
New research suggests that deploying strong and surprising messages could help to address overprescribing of opioids and other drugs.
Xianbao Liu, Qifeng Zhu, Fenfang Zheng & Jian’an Wang
Promoting collaboration between clinicians, researchers, device-makers, and regulators.
NEJM Catalyst Insights Council members say that while transparency might be necessary, we have to change the way care is delivered.
Efforts to mitigate rising health care costs have left most industry participants — patients, providers, and payers alike — frustrated at the lack of progress. While there is plenty of blame to go around, a significant open question remains: how responsible are patients for reducing costs?
John P. Andrawis, Mark McClellan & Kevin J. Bozic
Dell Medical School at The University of Texas at Austin has improved outcomes and reduced costs for musculoskeletal care with a multidisciplinary Musculoskeletal Institute and bundled payment model.
David Lansky & Jeff Micklos
Care management should be payer-agnostic at its core.
JP Sharp, Patrick H. Conway & Rahul Rajkumar
We believe North Carolina can be a model for the nation.
Nicholas Bagley, Amitabh Chandra, Craig Garthwaite & Ariel D. Stern
Three proposals for improving the law to reflect 21st-century drug development practices.